Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
Kristin C. Peck net worth and biography

Kristin Peck Biography and Net Worth

CEO of Zoetis
Prior to becoming CEO, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis.  Ms. Peck helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company including Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research.  

Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc. and as a member of Pfizer's Executive Leadership Team. In this role, she was responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses – paving the way for a public animal health company and attractive investment opportunity.  

Prior to joining Pfizer, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan.  

Ms. Peck is on the Board of BlackRock, the world’s largest asset management firm. She is also a member of the Business Roundtable and a Board member of Catalyst, a global non-profit that helps companies around the world accelerate women into leadership. In addition, she serves on the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. Named a Fortune 2020 Businessperson of the Year, Ms. Peck has been recognized for her leadership and Zoetis' strong performance, including its resilience during the COVID-19 pandemic. 

Ms. Peck holds a bachelor's degree from Georgetown University and an MBA from Columbia Business School.

What is Kristin C. Peck's net worth?

The estimated net worth of Kristin C. Peck is at least $6.26 million as of July 21st, 2022. Ms. Peck owns 39,743 shares of Zoetis stock worth more than $6,256,343 as of December 2nd. This net worth approximation does not reflect any other assets that Ms. Peck may own. Additionally, Ms. Peck receives an annual salary of $3,860,000.00 as CEO at Zoetis. Learn More about Kristin C. Peck's net worth.

How old is Kristin C. Peck?

Ms. Peck is currently 51 years old. There are 7 older executives and no younger executives at Zoetis. Learn More on Kristin C. Peck's age.

What is Kristin C. Peck's salary?

As the CEO of Zoetis Inc., Ms. Peck earned a total compensation package of $13,098,491.00 in 2021. Ms. Peck earned a salary of $1,200,000.00, stock awards of $6,929,797.00, options awards of $2,309,970.00, non-equity compensation of $2,340,000.00, and other compensation of $318,724.00. Learn More on Kristin C. Peck's salary.

How do I contact Kristin C. Peck?

The corporate mailing address for Ms. Peck and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected] Learn More on Kristin C. Peck's contact information.

Has Kristin C. Peck been buying or selling shares of Zoetis?

Kristin C. Peck has not been actively trading shares of Zoetis within the last three months. Most recently, Kristin C. Peck sold 9,689 shares of the business's stock in a transaction on Thursday, July 21st. The shares were sold at an average price of $180.00, for a transaction totalling $1,744,020.00. Following the completion of the sale, the chief executive officer now directly owns 39,743 shares of the company's stock, valued at $7,153,740. Learn More on Kristin C. Peck's trading history.

Who are Zoetis' active insiders?

Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.

Are insiders buying or selling shares of Zoetis?

In the last twelve months, insiders at the sold shares 11 times. They sold a total of 72,293 shares worth more than $13,563,344.69. The most recent insider tranaction occured on July, 22nd when EVP Roxanne Lagano sold 2,167 shares worth more than $390,623.42. Insiders at Zoetis own 0.1 % of the company. Learn More about insider trades at Zoetis.

Information on this page was last updated on 7/22/2022.

Kristin C. Peck Insider Trading History at Zoetis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/21/2022Sell9,689$180.00$1,744,020.0039,743View SEC Filing Icon  
7/7/2022Sell311$180.00$55,980.0039,743View SEC Filing Icon  
2/25/2022Sell10,000$192.29$1,922,900.00View SEC Filing Icon  
11/26/2021Sell14,500$223.10$3,234,950.00View SEC Filing Icon  
8/25/2021Sell14,500$203.55$2,951,475.0043,424View SEC Filing Icon  
11/25/2020Sell10,500$161.51$1,695,855.0038,374View SEC Filing Icon  
8/25/2020Sell10,500$157.61$1,654,905.0042,374View SEC Filing Icon  
5/26/2020Sell10,500$131.31$1,378,755.0043,759View SEC Filing Icon  
2/25/2020Sell11,925$138.10$1,646,842.5051,799View SEC Filing Icon  
11/12/2019Sell11,500$117.16$1,347,340.0044,877View SEC Filing Icon  
8/12/2019Sell11,500$123.22$1,417,030.0048,877View SEC Filing Icon  
5/13/2019Sell11,500$100.92$1,160,580.00View SEC Filing Icon  
2/12/2019Sell11,500$86.79$998,085.00View SEC Filing Icon  
11/12/2018Sell11,500$94.78$1,089,970.00View SEC Filing Icon  
8/1/2018Sell5,000$86.22$431,100.00View SEC Filing Icon  
5/1/2018Sell4,877$83.46$407,034.4242,652View SEC Filing Icon  
11/22/2016Sell10,092$49.55$500,058.6022,768View SEC Filing Icon  
See Full Table

Kristin C. Peck Buying and Selling Activity at Zoetis

This chart shows Kristin C Peck's buying and selling at Zoetis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zoetis Company Overview

Zoetis logo
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $157.42
Low: $152.40
High: $157.91

50 Day Range

MA: $147.83
Low: $131.14
High: $156.64

2 Week Range

Now: $157.42
Low: $124.15
High: $249.27


1,928,653 shs

Average Volume

2,571,268 shs

Market Capitalization

$73.37 billion

P/E Ratio


Dividend Yield



The Collapse of 2022 Has Begun
Almost every asset you own could be in grave danger -- stocks, bonds, real estate and even banks.

Today, Dr. Martin Weiss reveals his survival plan for these unprecedented times.

Protect your wealth now.